Could a menopause drug combo cut breast cancer risk?
Disease control
Completed
This pilot study tested whether a daily combination of bazedoxifene and conjugated estrogens could change breast tissue markers in 16 women at increased risk for breast cancer. The women, aged 45-65 with menopausal symptoms, took the drugs for 6 months. The goal was to see if the…
Phase: EARLY_PHASE1 • Sponsor: Carol Fabian, MD • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC